IP Library Granted Patent US 8,691,073
Granted Patent B2
US 8,691,073 · App. 13/214,643 · Granted Apr 8, 2014

Enzymatic electrochemical biosensor

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,691,073
App. No.
13/214,643
Granted
Apr 8, 2014
Kind
B2
Abstract

An electrochemical sensor strip has a base and a first electrode and a second electrode on the base. An oxidoreductase enzyme and a mediator are on the first electrode, and a soluble redox species is on the second electrode. The soluble redox species may be an organotransition metal complex, a transition metal coordination complex, an electroactive organic molecule, or mixtures thereof.

Claims (39)

1. A method of quantifying an analyte in a sample, comprising:

contacting the sample with an electrochemical sensor strip;

the electrochemical sensor strip before being contacted with the sample comprising a working electrode and a counter electrode, where

the working and the counter electrodes include compositions that are different from each other,

the composition of the working electrode includes a mediator and an oxidoreductase enzyme capable of facilitating a redox reaction of the analyte that is specific for the analyte, and

the composition of the counter electrode includes a first soluble redox species having a standard reduction potential of at least +0.24 volts in relation to a standard hydrogen electrode;

applying an electrical potential between the working and the counter electrodes;

stopping the electrical potential between the working and the counter electrodes;

reapplying the electrical potential between the working and the counter electrodes;

measuring a current passing through the working and the counter electrodes and the sample, where when the electrical potential is reapplied between the working and the counter electrodes,

a redox reaction at the working electrode is opposite a redox reaction at the counter electrode,

the mediator regenerates an oxidation state of the oxidoreductase enzyme after the redox reaction of the analyte,

the mediator undergoes the same redox reaction as the analyte at the working electrode,

the mediator undergoes the opposite redox reaction as the analyte when regenerating the oxidation state of the oxidoreductase enzyme,

the first soluble redox species undergoes the opposite redox reaction of the analyte, and

there is no detectable migration to the working electrode of reduced first soluble redox species produced at the counter electrode; and

correlating the current to a concentration of the analyte, where the correlation between the current and the concentration of the analyte is substantially linear from an analyte concentration of about 50 mg/dL to about 400 mg/dL.

2. The method of claim 1 , further comprising monitoring the electrical potential between the working and the counter electrodes with a third electrode, the third electrode including a second soluble redox species.

3. The method of claim 2 , where the second soluble redox species is the same composition as the first soluble redox species.

4. The method of claim 1 , where the mediator is an electroactive organic molecule.

5. The method of claim 4 , where the electroactive organic molecule is selected from the group consisting of coenzyme pyrroloquinoline quinone (PQQ), substituted benzoquinones, substituted naphthoquinones, N-oxides, nitroso compounds, hydroxylamines, oxines, flavins, phenazines, phenothiazines, indophenols, indamines, phenazinium salts, phenoxazinium salts, 3-phenylimino-3H-phenothiazines, 3-phenylimino-3H-phenoxazines, and mixtures thereof.

6. The method of claim 4 , where the electroactive organic molecule comprises a 3-phenylimino-3H-phenothiazine.

7. The method of claim 4 , where the electroactive organic molecule comprises a 3-phenylimino-3H-phenoxazine.

8. The method of claim 1 , where the analyte comprises glucose, and the oxidoreductase comprises glucose oxidase or glucose dehydrogenase.

9. The method of claim 1 , where the oxidoreductase comprises an enzyme selected from the group consisting of an oxidase and a dehydrogenase; and where the first soluble redox species is a reducible species.

10. The method of claim 2 , further comprising measuring a second electrical potential between the third electrode and the working electrode, and adjusting the electrical potential between the working and counter electrodes in response to the second electrical potential.

11. The method of claim 1 , where the correlation between the current and the concentration of the analyte is substantially linear from zero to an analyte concentration of about 400 mg/dL.

12. The method of claim 1 , where the correlation between the current and the concentration of the analyte is substantially linear from zero to an analyte concentration of about 600 mg/dL.

13. The method of claim 1 , where the sensor strip comprises:

a base;

a working electrode on the base;

a counter electrode on the base; and

a lid mated to the base, such that the lid is over the working and counter electrodes.

14. The method of claim 2 , where the sensor strip comprises:

a base;

the working electrode on the base;

the counter electrode on the base;

the third electrode on the base; and

a lid mated to the base, such that the lid is over the working, counter, and third electrodes.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2016
From: BAYER HEALTHCARE LLC
To: ASCENSIA DIABETES CARE HOLDINGS AG
Reel/Frame 037880/0604 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2014
From: WU, HUAN-PING; BEER, GREG P.; BLASCHKE, CHRISTINA
To: BAYER HEALTHCARE LLC
Reel/Frame 032084/0367 →